Valbiotis SA

ENXTPA:ALVAL Stock Report

Market Cap: €21.3m

Valbiotis Management

Management criteria checks 4/4

Valbiotis' CEO is Sebastien Peltier, appointed in Mar 2017, has a tenure of 7.75 years. total yearly compensation is €301.00K, comprised of 59.8% salary and 40.2% bonuses, including company stock and options. directly owns 4% of the company’s shares, worth €851.76K. The average tenure of the management team and the board of directors is 5.9 years and 7.2 years respectively.

Key information

Sebastien Peltier

Chief executive officer

€301.0k

Total compensation

CEO salary percentage59.8%
CEO tenure7.8yrs
CEO ownership4.0%
Management average tenure5.9yrs
Board average tenure7.2yrs

Recent management updates

Recent updates

Is Valbiotis (EPA:ALVAL) A Risky Investment?

Jun 20
Is Valbiotis (EPA:ALVAL) A Risky Investment?

Rock star Growth Puts Valbiotis (EPA:ALVAL) In A Position To Use Debt

May 09
Rock star Growth Puts Valbiotis (EPA:ALVAL) In A Position To Use Debt

Is Valbiotis (EPA:ALVAL) Using Debt In A Risky Way?

May 10
Is Valbiotis (EPA:ALVAL) Using Debt In A Risky Way?

Valbiotis SA (EPA:ALVAL) Is Expected To Breakeven In The Near Future

Mar 08
Valbiotis SA (EPA:ALVAL) Is Expected To Breakeven In The Near Future

CEO Compensation Analysis

How has Sebastien Peltier's remuneration changed compared to Valbiotis's earnings?
DateTotal CompensationSalaryCompany Earnings
Jun 30 2024n/an/a

-€9m

Mar 31 2024n/an/a

-€8m

Dec 31 2023€301k€180k

-€7m

Sep 30 2023n/an/a

-€8m

Jun 30 2023n/an/a

-€9m

Mar 31 2023n/an/a

-€11m

Dec 31 2022€318k€180k

-€12m

Sep 30 2022n/an/a

-€11m

Jun 30 2022n/an/a

-€10m

Mar 31 2022n/an/a

-€9m

Dec 31 2021€259k€180k

-€9m

Compensation vs Market: Sebastien's total compensation ($USD314.07K) is about average for companies of similar size in the French market ($USD317.65K).

Compensation vs Earnings: Sebastien's compensation has been consistent with company performance over the past year.

CEO

Sebastien Peltier (46 yo)

7.8yrs

Tenure

€301,000

Compensation

Mr. Sebastien Peltier, Ph D., HDR serves as the Chief Executive Officer of Valbiotis SA and is Co-Founder of Valbiotis. Mr. Peltier has been Member of Management Board of Valbiotis SA from March 7, 2017 an...

Leadership Team

NamePositionTenureCompensationOwnership
Sebastien Peltier
Co-Founder7.8yrs€301.00k4%
€ 851.8k
Sebastien Bessy
COO & Member of the Management Board3.5yrs€295.00k0.035%
€ 7.4k
Pascal Sirvent
CSO & Member of the Management Board6.3yrs€236.00k0.12%
€ 25.9k
Murielle Cazaubiel
CMO & Member of the Management Board5.9yrs€255.00k0.0026%
€ 553.3
Stanislas Sordet
CFO & Member of Management Boardless than a yearno datano data
Charlotte Jezequel
Director of HR & Member of Management Board1.9yrsno datano data
Josep Infesta
Head of Global Business Development5.9yrsno datano data

5.9yrs

Average Tenure

Experienced Management: ALVAL's management team is seasoned and experienced (5.9 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Agnes Tixier
Member of Supervisory Board5.8yrsno datano data
Laurent Levy
Chairman of Supervisory Board7.8yrsno datano data
Nathalie Boisseau
Member of Scientific & Medical Boardno datano datano data
Jean-Marie Bard
Member of Scientific & Medical Boardno datano datano data
Samy Hadjadj
Member of Scientific & Medical Boardno datano datano data
Thierry Maugard
Member of Scientific & Medical Boardno datano datano data
Bruno Guigas
Member of Scientific & Medical Boardno datano datano data
Jean Zetlaoui
Member of Supervisory Board7.2yrsno datano data

7.2yrs

Average Tenure

Experienced Board: ALVAL's board of directors are considered experienced (7.2 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/22 02:15
End of Day Share Price 2024/12/20 00:00
Earnings2024/06/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Valbiotis SA is covered by 3 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Martial DescouturesODDO BHF Corporate & Markets
Mohamed KaabouniPortzamparc BNP Paribas
Corentin MartyTPICAP Midcap